{"fund":{"name":"Series Fund - Developing Growth Portfolio","canonicalUrls":["https://www.lordabbett.com/en-us/individual-investor/index/investments-and-performance/series-funds/us-equity/developing-growth-portfolio.html.class-vc","https://www.lordabbett.com/en-us/financial-advisor/index/investments-and-performance/series-funds/us-equity/developing-growth-portfolio.html.class-vc"],"assetClass":"U.S. Equity","fundType":"Series Fund","cusip":"543910855","shareClass":"VC"},"overview":{"summary":"The Fund’s investment objective is long-term growth of capital."},"holdings":{"asOfDate":"08/31/2026","topHoldings":[{"name":"Guardant Health Inc","percentageOfAssets":3.01},{"name":"Navan Inc","percentageOfAssets":2.62},{"name":"JFrog Ltd","percentageOfAssets":2.56},{"name":"10X Genomics Inc","percentageOfAssets":2.07},{"name":"Twist Bioscience Corp","percentageOfAssets":1.92},{"name":"SiTime Corp","percentageOfAssets":1.9},{"name":"DigitalOcean Holdings Inc","percentageOfAssets":1.88},{"name":"Madrigal Pharmaceuticals Inc","percentageOfAssets":1.75},{"name":"IMAX Corp","percentageOfAssets":1.75},{"name":"Cogent Biosciences Inc","percentageOfAssets":1.68}]}}